Skip to main content
. 2021 Aug 17;12(17):1687–1696. doi: 10.18632/oncotarget.28035

Table 1. Characteristics of patients enrolled in the open-label study.

PDAC
Number of cases 83
Age 71.0 ± 8.7 (41–87)
Sex (M/F) 56/27
Pathological stage (0/IA/IB/IIA/IIB/III/IV) 5/20/4/28/23/0/3
CA19-9 31.0 ± 1279.7 (0.6–8997.0)
CEA 2.7 ± 3.8 (0.3–29.0)